Stanford Study Reveals Gene Impact on Neurodevelopmental Diseases miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
New techniques for growing human brain tissue in the lab are fueling a revolution in scientists' ability to observe human brain development, trace the origins of psychiatric disorders and develop new treatments. Featuring Stanford psychiatry professor Sergiu Pasca.
AUCKLAND, New Zealand, Jan. 26, 2023 /PRNewswire/ Douglas Pharmaceuticals, a New Zealand Pharmaceutical company focused on specialty generic and repurposed drug development, today announced
Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.